berberine has been researched along with Parkinson Disease, Secondary in 1 studies
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Berberine (BBR) is a renowned natural compound that exhibits potent neuroprotective activities." | 1.46 | Berberine protects against 6-OHDA-induced neurotoxicity in PC12 cells and zebrafish through hormetic mechanisms involving PI3K/AKT/Bcl-2 and Nrf2/HO-1 pathways. ( Bao, J; Chen, M; Chen, S; He, C; Jia, X; Lee, SMY; Li, C; Li, P; Li, Z; Liang, Y; Liu, K; Su, H; Wan, JB; Wang, K; Wang, X; Zhang, C, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, C | 1 |
| Li, C | 1 |
| Chen, S | 1 |
| Li, Z | 1 |
| Jia, X | 1 |
| Wang, K | 1 |
| Bao, J | 1 |
| Liang, Y | 1 |
| Wang, X | 1 |
| Chen, M | 1 |
| Li, P | 1 |
| Su, H | 1 |
| Wan, JB | 1 |
| Lee, SMY | 1 |
| Liu, K | 1 |
| He, C | 1 |
1 other study available for berberine and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Berberine protects against 6-OHDA-induced neurotoxicity in PC12 cells and zebrafish through hormetic mechanisms involving PI3K/AKT/Bcl-2 and Nrf2/HO-1 pathways.
Topics: Animals; Antioxidants; Apoptosis; Berberine; Cell Survival; Disease Models, Animal; Dopaminergic Neu | 2017 |